It looks like the last obstacle blocking Anderson Silva and Chael Sonnen’s blockbuster rematch has been cleared.
Today, the Nevada State Athletic Commission granted Sonnen’s request for a therapeutic use exemption for his usage of testosterone replacement therapy. This means that Sonnen will be allowed to supplement his naturally-occurring testosterone levels with TRT as long as he tests within the allowable ratio (6:1 in Nevada) come fight time.
Sonnen appeared in front of the NSAC as part of their monthly meeting, which also included Nick Diaz’s hearing over possible disciplinary action for testing positive for marijuana metabolites.
Sonnen found himself in hot water following his first fight with Silva (which he lost by submission) after registering an elevated testosterone-to-epitestosterone ratio on a post-fight drug test, as well as for improperly disclosing his usage of TRT with the California State Athletic Commission.
Barring any unforeseen obstructions, it would appear that Silva-Sonnen 2 is a go. The two fighters are scheduled to dispute Silva’s middleweight title on July 7 at UFC 148, which is scheduled to take place at the MGM Grand Garden Arena in Las Vegas.